Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotinic agonist presented as a transdermal patch for transdermal use. It is indicated for adult smokers seeking to quit by providing a controlled release of nicotine to alleviate withdrawal symptoms and cravings, supporting a gradual reduction in tobacco dependence.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Nicorette Invisipatch, a nicotine replacement therapy, is used in smoking cessation. - Smoking cessation: helps adult smokers reduce withdrawal symptoms and gradually discontinue tobacco use. - Tobacco dependence: provides a steady nicotine dose to support quitting efforts. - Relapse prevention: assists recent quitters in maintaining abstinence from cigarettes.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Sleep disturbance: insomnia or vivid dreams. - Nausea: mild stomach upset. - Headache: transient tension-type headache. - Dizziness: light‑headed feeling. - Mouth irritation: tingling or dryness.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Extensive skin rash: blistering or severe dermatitis. - Cardiovascular events: chest pain, palpitations, or hypertension. - Hypotension: marked drop in blood pressure. - Arrhythmia: irregular heart rhythm. - Severe dizziness or fainting.

Before using Nicorette Invisipatch, consider the following precautions: - Assess nicotine dependence level: determine appropriate patch strength. - Avoid use in non‑smokers or occasional smokers: unnecessary nicotine exposure. - Do not apply to damaged or irritated skin: may increase irritation. - Do not combine with other nicotine replacement products: risk of nicotine overdose. - Monitor cardiovascular status: patients with heart disease should use under medical supervision. - Store at room temperature: keep in the original pouch, protect from moisture and direct heat.

Nicorette Invisipatch may interact with other medicines. Review the following groups:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify nicotine’s cardiovascular effects. - CYP2A6 inhibitors (e.g., methoxsalen): can raise systemic nicotine levels. - Insulin or oral hypoglycemics: nicotine may affect glucose control.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): monitor for increased side‑effects such as insomnia. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Theophylline: nicotine can alter plasma concentrations, requiring dose adjustment.